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OBJECTIVES This study sought to determine whether abnormal ventricular repolarization is implicated in
cardiac arrhythmias of German shepherd dogs with inherited sudden death.
BACKGROUND Moı¨se et al. (9) have identified German shepherd dogs that display pause-dependent lethal
ventricular arrhythmias.
METHODS Ventricular repolarization was studied both in vivo using electrocardiogram recordings on
conscious dogs and in vitro with a standard microelectrode technique performed on
endomyocardial biopsies and Purkinje fibers. Pharmacological manipulation was used to
evaluate the role of potassium channels.
RESULTS In control conditions, electrocardiogram parameters were similar in both groups of dogs,
except for the PR interval (18% longer in affected dogs, p , 0.05). Injection of d,l-sotalol
(2 mg/kg) prolonged QT interval more in affected dogs (114%, n 5 9) than it did in
unaffected dogs (16%, n 5 6, p , 0.05) and increased the severity of arrhythmias in affected
dogs. In vitro, in control conditions, action potential duration (APD90) of endomyocardial
biopsies and Purkinje fibers were significantly longer in affected dogs (respectively 209 6
3 ms, n 5 30 and 352 6 15 ms, n 5 17) than they were in unaffected dogs (197 6 4 ms, n 5
25 and 300 6 9 ms, n 5 30) at a pacing cycle length (PCL) of 1,000 ms. This difference
increased with PCL. The kinetics of adaptation of APD90 to a change in PCL was faster in
affected dogs. D,l-sotalol (1025 and 1024M) increased APD90 in both groups of dogs, but
this increase was greater in affected dogs, with the occurrence of triggered activity on Purkinje
fibers. E-4031 (1027 and 1026 M), an IKr-blocker, increased APD90 similarly in both groups
of dogs. Chromanol 293B (1026 and 1025M), an IKs-blocker, increased significantly APD90
in unaffected dogs but had no effect in affected dogs.
CONCLUSIONS These results support the hypothesis of an abnormal cardiac repolarization in affected dogs.
The effects of 293B suggest that IKs may be involved in this anomaly. (J Am Coll Cardiol
2000;36:939–47) © 2000 by the American College of Cardiology
Sudden cardiac death is a major cause of death in developed
countries. Most commonly, the underlying mechanism is
ventricular tachycardia or fibrillation in association with
organic heart disease (1). However, cardiac arrhythmia-
induced sudden death was also observed in subpopulations
of patients with structurally normal hearts. These included
patients with various forms of long QT syndrome (2) but
also patients without delayed ventricular repolarization such
as patients with short-coupled ‘torsades de pointes’ (3),
catecholamine-induced ventricular tachycardia (4) or idio-
pathic ventricular fibrillation, so called ‘Brugada syndrome’
(5). In these patients, sudden death usually occurs at a young
age and sometimes without any previous alarming symp-
toms. Finally, lethal arrhythmias were also suggested to
contribute to some cases of sudden infant death syndrome
(6). The identification of patients at risk is difficult because
the mechanisms responsible for the lethal arrhythmias
remain largely unknown mainly because of a lack of suitable
animal models (7,8).
Recently, one of us has established a colony of German
shepherd dogs with ventricular arrhythmias and sudden
death (9), inherited as a simple autosomal dominant with
incomplete penetrance or polygenic trait (10). In these
animals, arrhythmias and death occur at a young age (10)
and are not associated with a structural heart disease. The
phenotype spectrum of the arrhythmias is wide, ranging
from infrequent premature ventricular beats to nonsustained
polymorphic ventricular tachycardia, with sometimes a ‘tor-
sades de pointes’-like morphology. Usually (more than 80%
of cases) the incidence of arrhythmias is increased at low
heart rates (HR) and after sinus pauses. All these features
are typically those observed in patients with long QT
syndrome although prolongation of the QT interval was not
found in affected dogs. However, that QT interval is normal
does not mean that the affected dogs do not have abnormal
ventricular repolarization. Indeed, affected dogs have more
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frequent notching of the T-waves (10) than unaffected dogs.
Moreover, left ventricular Purkinje fibers isolated from
affected dogs exhibit early afterdepolarizations (EADs) and
triggered activity (TA) (11,12), a potential mechanism for
lethal arrhythmias (7,13).
We, therefore, decided to further investigate the ventric-
ular repolarization of these German shepherds. We evalu-
ated the effects of d,l-sotalol, a beta-adrenergic blocking
agent also known to block potassium channels (14,15), on
action potentials (AP) and electrocardiogram (ECG). We
finally assessed the in vitro effects of two specific blockers of
the rapid and the slow components of the delayed rectifier
potassium current (IK): E-4031, an IKr-blocker (16) and
chromanol 293B, and IKs-blocker (17).
METHODS
This investigation conforms with the position of the Amer-
ican Heart Association on research animal use, adopted by
the American Heart Association November 11, 1984.
Animals. The dogs used for this study were part of a colony
implanted in the Veterinary School of Nantes, France, and
developed from five affected dogs coming from the colony of
Cornell University (9). The incidence and severity of cardiac
arrhythmias were assessed using Holter monitoring and
challenges with phenylephrine (18). The affected group (14
dogs) was comprised of inbred German Shepherds that
displayed frequent ventricular premature beats and nonsus-
tained ventricular tachycardia spontaneously or after phen-
ylephrine injections. The unaffected group (29 dogs) was
comprised of 20 inbred German shepherds, 3 Beagles,
6 mongrel dogs from two F1 generations—resulting from
the crossing of affected dogs with pure Labradors—that did
not display arrhythmias.
In vivo studies. Nine unaffected dogs (29 to 52 weeks old;
38 6 2) and six affected dogs (30 to 49 weeks old; 38 6 3)
Abbreviations and Acronyms
ANS 5 autonomic nervous system
AP 5 action potential
APD 5 action potential duration
EADs 5 early afterdepolarizations
ECG 5 electrocardiogram
HR 5 heart rate
IV 5 intravenous
PCL 5 pacing cycle length
TA 5 triggered activity
Figure 1. Left panels. Effects of d,l-sotalol on (A) heart rate (HR), (B) PR interval duration (PR) and (C) QT interval duration (QT) in unaffected dogs
(n 5 9, solid circle) and affected dogs (n 5 6, solid triangle). See protocol in Methods section. (B) #p , 0.05, that is, the two curves are parallel and
significantly separated (two-way analysis of variance). (C) For better clarity, we plotted the sotalol-induced increase in QT interval. Values of the QT
interval at t 5 0 were 227 6 5 ms in unaffected dogs and 219 6 8 ms in affected dogs (NS vs. unaffected). *p , 0.05, that is, the effect of sotalol is greater
in affected dogs (two-way analysis of variance performed on raw QT values). Right panels. Typical electrocardiogram recordings obtained in (D) in
unaffected dog and (E) an affected dog under controlled conditions (top) and 15 min after the second injection of d,l-sotalol (bottom). Vertical bars, 20 mV;
horizontal bars, 1 s. See text for further explanation. bpm 5 beats per min.
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were used to evaluate the ECG effects of d,l-sotalol. Three
leads ECG (I, II, III) were continuously monitored on
conscious dogs lying quietly in a hammock. Measurements
were made on lead II. They included HR, QT interval
(measured as described by Weissenburger et al. [19]) and
PR duration. Baseline measurements were made at least
30 min after the end of the instrumentation. Then, atenolol
(Tenormine i.v., Zeneca Pharma, France) was injected as an
intravenous (IV) bolus of 2 mg/kg followed (during the
whole experiment) by a perfusion of 0.3 mg/kg/h. Beta-
blockade with atenolol allowed us to have homogenized
groups of dogs with similar levels of sympathetic input
(similar HR) to study only the class III effects of d,l-sotalol,
which is also a beta-blocker, and to decrease HR, which
may facilitate the occurrence of bradycardia-dependent
arrhythmias in affected dogs (12), those that were of interest
for this study. D,l-sotalol (Sotalex, i.v., Bristol-Myers-
Squibbs, France) was injected twice as an IV bolus of
2 mg/kg, 15 (time t0) and 45 min after the IV bolus of
atenolol. Electrocardiogram measurements were done 15,
30, 45 and 60 min after t0.
In vitro studies. Endomyocardial biopsies. Dogs were anes-
thetized with an IV bolus of ketamine (0.7 mg/kg; Imal-
ge`ne, Rhoˆne-Me´rieux, France) and xylazine (0.7 mg/kg;
Rompun, Bayer, Germany). The biotome (Cordis
7F/2.2 mm; Cordis, S.A., France) was advanced to the right
ventricle through the right jugular vein. Each biopsy (4 to 5
in each dog) excised from the septal subendocardium was
immersed quickly in a cold Tyrode’s solution containing (in
mM): NaCl, 124; NaHCO3, 27; NaH2PO4, 1.8; KCl, 4;
MgCl2, 0.5; CaCl2, 2.7; glucose, 5 (pH 7.4).
Purkinje fibers. Dogs were anesthetized with pentobarbi-
tal sodium (30 mg/kg IV, Pentobarbital sodique, Sanofi,
France). The hearts were quickly removed through a left
thoracotomy and immersed in a cold Tyrode’s solution (see
preceding text). Purkinje fibers were dissected from both
ventricles.
Experimental protocols. The tissues were mounted in a
Lucite chamber perfused with an oxygenated (95% O2–5%
CO2) Tyrode’s solution warmed to 37 6 0.5°C. Transmem-
brane recordings were obtained as previously described (20)
and analyzed with the software Acquis1 (Biologic, France).
The tissues were allowed to recover for at least 1 h before
the experiments were started. During this period, they were
driven at a pacing cycle length (PCL) of 1,000 ms by field
or bipolar stimulation through Teflon-coated silver wire
electrodes. Stimulus pulse width was 0.5 to 1.5 ms, and
amplitude was twice diastolic threshold.
To study the effects of pacing on repolarization, the
preparations were driven at PCL decreasing from 8,000 to
300 ms. Action potential characteristics were measured at
steady state for each PCL. We measured the resting
potential—or the maximal diastolic potential for Purkinje
fibers—the action potential amplitude, the maximum up-
Table 1. Evolution of Arrhythmias in Affected Dogs During
D,l-sotalol Protocols (Maximum Number of Arrhythmias/min)
Dogs Before Sotalol After Sotalol
TAN742 26 VPB 50 VPB
5 doublets 10 doublets
M3 25 VPB 44 VPB
5 doublets
1 VT
M7 1 VPB 8 VPB
N20 — —
N12 — 5 VPB
N17 1 VPB 5 VPB
2 doublets
5 triplets
3 VT
— 5 no arrhythmia; VPB 5 ventricular premature beat; VT 5 ventricular
tachycardia.
Table 2. Electrophysiological Characteristics of Action Potentials Recorded From Canine
Endomyocardial Biopsies and Purkinje Fibers Paced at a Cycle Length of 1,000 ms in
Control Conditions
Endomyocardial Biopsies Purkinje Fibers
Unaffected
(n 5 25, 17 Dogs,
40 6 4 Weeks)
Affected
(n 5 30, 12 Dogs,
42 6 3 Weeks)
Unaffected
(n 5 30, 13 Dogs,
47 6 5 Weeks)
Affected
(n 5 17, 6 Dogs,
49 6 3 Weeks)
RP/MDP (mV) 292 6 1 292 6 1 290 6 1 290 6 1
APA (mV) 119 6 1 121 6 1 124 6 1 125 6 1
Vmax (V/s) 360 6 28 344 6 21 538 6 28 519 6 31
Phase 1 (mV) 100 6 2 103 6 2 101 6 1 101 6 1
Phase 2 (mV) 104 6 1 108 6 1* 102 6 1 102 6 1
APD30 (ms) 103 6 4 117 6 4* 114 6 7 108 6 8
APD50 (ms) 156 6 3 168 6 4* 226 6 8 250 6 13
APD70 (ms) 184 6 4 197 6 3* 264 6 9 307 6 14†
APD90 (ms) 197 6 4 209 6 3* 300 6 9 352 6 15†
Values are expressed as mean 6 SEM, rounded off to nearest whole number. The number of experiments and dogs and their
mean age are given in parentheses.
APA 5 action potential amplitude; APD30, APD50, APD70 and APD90 5 action potential duration at 30, 50, 70 and 90%
of full repolarization, respectively; MDP 5 maximum diastolic potential (for Purkinje fibers); phase 1 5 phase 1 amplitude;
phase 2 5 phase 2 amplitude; RP 5 resting potential (for endomyocardial biopsies); Vmax 5 maximum upstroke velocity of
phase 0.
*p , 0.05 and †p , 0.01 versus unaffected (Student t test).
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stroke velocity of phase 0, the phase 1 and phase 2 ampli-
tudes (differences between resting potential or maximal
diastolic potential and the potential at the end of phase 1 or
the top of phase 2, respectively) and the action potential
duration (APD) at 30% (APD30), 50% (APD50), 70%
(APD70) and 90% (APD90) of full repolarization. The same
pacing protocol was performed after 15 min of superfusion
with d,l-sotalol (1025 and 1024M), E-4031 (1027 and
1026M, custom synthesized according to [21]) or chroma-
nol 293B (293B; 1026 and 1025 M, gift from Hœchst,
Germany). E-4031 and 293B were dissolved in distilled
water and dimethyl-sulfoxide, respectively. Between the
pacing protocols, the tissues were driven at a PCL of
1,000 ms.
To study the kinetics of adaptation of repolarization to
sudden changes in pacing rate, the samples were driven at
PCL increasing abruptly from 300 to 1,000 ms and from
1,000 to 8,000 ms or decreasing abruptly from 8,000 to
1,000 ms and from 1,000 to 300 ms. During the periods of
adaptation after the changes in PCL (up to 4 min), all the
AP were recorded. Their APD90 values were plotted versus
time. The plots were then fitted using the software Sig-
maPlot 4.0 (SPSS Inc.) with monoexponential equations for
increasing PCL protocols: y 5 y0 1 az(1-exp [2bzx]) and
biexponential equations for decreasing PCL protocols: y 5
y0 1 azexp (2bzx) 1 czexp (2dzx). Time-constants (tau 5
1/b and tau9 5 1/d) obtained from both groups of dogs were
then compared.
Statistical analysis. Data are expressed as mean 6 SEM.
Statistical analysis was performed with the Student t test or
with the one-way or two-way analysis of variance completed
by a t test for multiple comparisons (Bonferroni procedure)
when adequate. Statistical significance was set at p , 0.05.
RESULTS
In vivo studies. In control conditions, HR and QT interval
duration were similar in affected and unaffected dogs (re-
spectively, 106 6 4 vs. 96 6 8 beats/min for HR, NS and
206 6 8 vs. 216 6 6 ms for QT interval, NS). In contrast,
the PR interval was longer in affected dogs (117 6 7 ms)
than it was in unaffected dogs (99 6 3 ms, p , 0.05).
Effects of d,l-sotalol were assessed after beta-blockade
with atenolol. Atenolol decreased HR and increased PR and
QT intervals significantly and similarly in both groups.
D,l-sotalol further decreased HR (Fig. 1A) similarly in both
groups and had no effect on PR interval (Fig. 1B). It
prolonged the QT interval in both groups (Fig. 1C) but
more in affected dogs than in unaffected ones (15 min after
the second injection of d,l-sotalol; 31 6 5 ms and 14 6 3 ms
respectively, p , 0.05). None of the unaffected dogs
displayed arrhythmias during these experiments. Arrhyth-
mic events occurring in affected dogs are summarized in
Table 1.
In vitro studies. Electrophysiological characteristics of endo-
myocardial biopsies and Purkinje fibers in control conditions.
Table 2 summarizes the control electrophysiological char-
acteristics of endomyocardial biopsies and Purkinje fibers
obtained from unaffected and affected dogs at steady-state
(PCL 5 1,000 ms). Resting potential, action potential
amplitude, maximum upstroke velocity of phase 0 and phase
1 amplitude were similar in both groups. In contrast, APD
of biopsies and Purkinje fibers was significantly longer in
affected dogs than it was in unaffected ones, especially at
long PCL (Fig. 2) (Fig. 5 [12] for Purkinje fibers). This
APD prolongation was much greater on Purkinje fibers
(Table 2). In control conditions, when PCL increased from
1,000 ms to 8,000 ms, APD90 increased by 85% in affected
dogs (from 358 6 16 ms to 664 6 72 ms) and by only 60%
in unaffected dogs (from 302 6 9 ms to 484 6 27 ms).
Consequently, at long PCL, EADs were observed in 41% of
Purkinje fibers of affected dogs (and TA in 18%) but in none
of the Purkinje fibers of unaffected dogs.
We focused our study of the kinetics of adaptation of
APD90 on slow changes described by Boyett et al. (22) on
canine Purkinje and ventricular fibers. In controlled dogs,
time-constants in myocardium were lower than they were in
Figure 2. (A) Typical superimposed endomyocardial action potentials
recorded in an unaffected dog (left) and an affected dog (right) under
control conditions at PCL 5 1,000 ms and PCL 5 8,000 ms. Vertical bar,
50 mV; horizontal bar, 100 ms. (B) Effects of PCL on APD at 30% (left)
and 90% (right) of full repolarization (APD30 and APD90) of endomyo-
cardial biopsies obtained from 17 unaffected dogs (n 5 25 samples, open
circle) and 12 affected dogs (n 5 30 samples, open triangle) under control
conditions. In both graphs, the two curves are significantly separated
(two-way analysis of variance). APD 5 action potential duration; PCL 5
pacing cycle length.
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Purkinje fibers, suggesting that the adaptation of APD90 is
faster on myocardium as previously described by Robinson
et al. (23). In affected dogs, time-constants were about 30%
lower than they were in unaffected dogs on both tissues and
for all protocols (Table 3), which means that the adaptation
of APD90 to a decrease or an increase in PCL was faster in
affected dogs than it was in unaffected ones (Fig. 3 for
Purkinje fibers) despite bigger differences in steady-state
values of APD90 between long and short PCL in affected
dogs.
Cellular electrophysiological effects of d,l-sotalol. As shown
in Table 4 and Figure 4, d,l-sotalol prolonged endomyocar-
dial AP in both groups of dogs but more in affected dogs
than it did in unaffected dogs (23% vs. 11% at 1024 M for
APD90 at PCL 5 1,000 ms, p , 0.05; Fig. 4A) and at a
lower concentration (1025 M). Furthermore, on one biopsy
of an affected dog, d,l-sotalol 1024 M even induced EADs
at PCL 5 8,000 ms. This was never observed in unaffected
dogs. D,l-sotalol had no effect on other AP parameters.
D,l-sotalol prolonged Purkinje fibers AP in both groups of
dogs (Table 4, Fig. 4). But because d,l-sotalol increased the
frequency of EADs and TA or induced them in most
affected dogs, APD90 could not be measured at longer PCL
in all experiments. Therefore, the PCL-APD90 relationship
shown in Fig. 4B is not fully representative of the d,l-sotalol
effects in affected dogs. More precisely, TA was observed on
4/5 Purkinje fibers in the presence of d,l-sotalol 1024 M at
PCL 5 8,000 ms, on 2/5 fibers in the presence of d,l-sotalol
1025 M and 1024 M at PCL $ 4,000 ms and on 1/5 fiber
in the presence of d,l-sotalol 1024 M at PCL 5 2,000 ms
(as shown in Fig. 4B). Triggered activity was never observed
in unaffected dogs.
Cellular electrophysiological effects of E-4031. On both
types of cardiac tissues, E-4031 prolonged AP similarly in
both groups of dogs (Table 4, and Fig. 5). E-4031 had no
effect on other AP parameters.
In control conditions on endomyocardial biopsies, EADs
were not observed in any groups of dogs. E-4031 1026M
induced EADs in 5/6 samples in the unaffected group and
in 4/7 biopsies in affected dogs. On Purkinje fibers in
control conditions, EADs were not observed in
the unaffected group, whereas 1/5 fibers exhibited EADs
in the affected group. In the presence of E-4031 1026M,
5/9 Purkinje fibers of unaffected dogs displayed EADs or
TA at PCL 5 8,000 ms, versus 3/5 fibers of affected dogs
in the same conditions.
Cellular electrophysiological effects of chromanol 293B. As
shown in Table 4 and Figure 6, 293B slightly but signifi-
cantly prolonged AP on both endomyocardial biopsies and
Purkinje fibers in unaffected dogs but had no effect in
affected dogs. After superfusion with 293B 1025 M, there
was no more difference in endomyocardial APD90 between
both groups of dogs. 293B had no effect on other AP
parameters.
The increase in APD90 due to 293B in unaffected dogs
was larger at long PCL. At 1025 M, EADs were observed
on one Purkinje fiber of an unaffected dog at PCL 5
8,000 ms. This fiber had no EADs in control conditions.
The number of Purkinje fibers of affected dogs (2/5)
exhibiting EADs or TA under control conditions did not
increase in the presence of 293B.
DISCUSSION
In previous studies (9,10,18), the phenotype of German
shepherds predisposed to sudden death has been character-
ized. Dogs with strong phenotype exhibit rapid ventricular
tachyarrhythmias usually preceded by a sinus pause or
bradycardia. Consistently, the arrhythmias disappear during
sinus tachycardia. The most severe arrhythmias resemble
‘torsade de pointes,’ the arrhythmias occurring in patients
with long QT syndrome. However, affected dogs do not
have a long QT interval, although they present frequent
Table 3. Time Constants of Adaptation of the APD90 to a Change in Pacing Cycle Length on
Endomyocardial Biopsies and Purkinje Fibers in Control Conditions
Tissues Endomyocardial Biopsies Purkinje Fibers
Dogs
Unaffected
(4 Dogs,
40 6 2 Weeks)
Affected
(4 Dogs,
35 6 3 Weeks)
Unaffected
(7 Dogs,
49 6 6 Weeks)
Affected
(4 Dogs,
46 6 3 Weeks)
300–1,000 ms n 5 6 n 5 7 n 5 17 n 5 11
tau (s) 45 6 5 31 6 3* 58 6 5 44 6 4*†
1,000–8,000 ms n 5 6 n 5 6 n 5 7 n 5 10
tau (s) 44 6 7 34 6 4 108 6 13† 80 6 8*†
8,000–1,000 ms n 5 5 n 5 6 n 5 13 n 5 12
tau (s) 1.7 6 1.3 1.6 6 0.5 1.5 6 0.3 1.3 6 0.2
tau’ (s) 30 6 10 17 6 2 61 6 6† 44 6 5*†
1,000–300 ms n 5 5 n 5 6 n 5 14 n 5 10
tau (s) 1.3 6 0.4 1.2 6 0.2 2.0 6 0.4 1.8 6 0.3
tau’ (s) 18 6 1 13 6 2* 37 6 6 22 6 3*
Values are expressed as mean 6 SEM, rounded off to nearest whole number. The number of dogs and their mean age are given
in parentheses. The number of experiments is given in italics. See protocol in Methods section.
tau and tau’ 5 means of time-constants measured in all experiments.
*p , 0.05 versus unaffected; †p , 0.05 versus endomyocardium.
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notching of the T-wave. Moreover, arrhythmias are often
associated with variations of the T-wave morphology, sug-
gesting they could depend on abnormalities of repolariza-
tion.
Abnormal cardiac repolarization. D,l-sotalol is a beta-
blocker with class III antiarrhythmic properties (15,24).
This drug is known to cause severe cardiac arrhythmias in
patients or animal models with prolonged QT interval
(25,26) but also in patients with otherwise normal QT
interval (25). In vitro, it was shown that d,l-sotalol prolongs
AP mainly through a block of the delayed rectifier potas-
sium current IK (27) and can induce EADs (28). In this
study in control conditions, QT interval was similar in both
unaffected and affected dogs. But affected dogs presented a
greater increase in QT interval than unaffected ones. Con-
sistently, the incidence and severity of arrhythmias increased
after d,l-sotalol injection. D,l-sotalol had no proarrhythmic
effect in unaffected dogs. In vitro in control conditions, AP
recorded from endomyocardium and Purkinje fibers are
longer in affected dogs than they are in unaffected ones.
This difference is more pronounced as PCL lengthens, with
the occurrence of EADs and TA in affected dogs. This
could explain the bradycardia dependence of ventricular
arrhythmias observed in vivo. Consistently in vitro, the
increase in APD on endomyocardium and Purkinje fibers
induced by d,l-sotalol was greater in affected dogs leading to
the occurrence of EADs and TA on Purkinje fibers and in
one endomyocardial biopsy, confirming that this abnormal-
ity could be the trigger of the arrhythmias in vivo (11,12).
Our results also show that the adaptation of APD90 to
changes in PCL is faster in affected dogs. In other words in
affected dogs when HR slows down, APD would lengthen
more and more rapidly. But because sinus variability is large
in dogs, there is no available effective method to perform
computer analysis of the QT/RR relationship as it is done in
humans, so we can only speculate that the QT adaptation to
changes in HR would be faster in the affected dogs. This
Figure 3. Effects on Purkinje fibers APD90 of an abrupt change in PCL
from 300 to 1,000 ms (A) and from 1,000 to 300 ms (B), as illustrated
above the graph (horizontal bar, 1 s). Action potential duration90 (Y-axis)
is plotted versus time (X-axis), 0 corresponding to the change in PCL.
Action potential duration90 values are expressed as the percentage of the
steady-state value. For each sample, the APD90/time curve was fitted using
a monoexponential function (see Methods section). Function parameters
were averaged, and the resulting curves are shown in dotted lines for
unaffected dogs and solid lines for affected ones. Corresponding equations
are in (A) y 5 (255 1 73zexp[1-0.0194zx])/328z100 for unaffected dogs
(n 5 17) and y 5 (284 1 75zexp[120.0240zx])/359z100 for affected dogs
(n 5 11), in (B) y 5 (184 1 48zexp [20.7130zx] 1 34z[20.0686zx])/
195z100 for affected dogs (n 5 10). Inserts: Average time-constants (t in
A and t’ in B) in unaffected (white) and affected dogs (black). *p , 0.05
(Student t test). APD 5 action potential duration; PCL 5 pacing cycle
length.
Table 4. Effects of D,l-sotalol, E-4031 and Chromanol 293B on Repolarization of Canine Endomyocardial Biopsies and Purkinje
Fibers Paced at a Cycle Length of 1,000 ms
D,1-sotalol E-4031 Chromanol 293B
Biopsies
APD90 (ms)
Purkinje
APD90 (ms)
Biopsies
APD90 (ms)
Purkinje
APD90 (ms)
Biopsies
APD90 (ms)
Purkinje
APD90 (ms)
Unaffected (n 5 7, 6 dogs,
34 6 4 weeks)
(n 5 6, 5 dogs,
44 6 2 weeks)
(n 5 6, 5 dogs,
40 6 3 weeks)
(n 5 9, 8 dogs,
49 6 8 weeks)
(n 5 6, 5 dogs,
45 6 14 weeks)
(n 5 9, 5 dogs,
51 6 13 weeks)
Control 188 6 8 265 6 19 195 6 4 308 6 13 204 6 5 311 6 20
First dose 193 6 7 299 6 21 227 6 7* 470 6 24* 208 6 5 321 6 18
Second dose 217 6 8* 398 6 33* 256 6 12* 538 6 35* 210 6 5* 331 6 23*
Affected (n 5 8, 6 dogs,
41 6 5 weeks)
(n 5 5, 4 dogs,
50 6 2 weeks)
(n 5 7, 6 dogs,
41 6 2 weeks)
(n 5 5, 5 dogs,
35 6 7 weeks)
(n 5 5, 5 dogs,
55 6 10 weeks)
(n 5 5, 4 dogs,
41 6 6 weeks)
Control 203 6 6 304 6 7 210 6 7 324 6 25 209 6 6 370 6 28
First dose 220 6 7* 345 6 9 241 6 9* 489 6 66* 208 6 4 375 6 25
Second dose 250 6 10* 451 6 24* 278 6 15 566 6 60* 209 6 5 373 6 24
Values are expressed as mean 6 SEM, rounded off to nearest whole number. The number of experiments, the number of dogs and their mean age are given in parentheses,
respectively.
APD90 5 action potential duration at 90% of full repolarization respectively; first dose 5 first concentration of each drug, respectively 10
25, 1027 and 1026 M for d,l-sotalol,
E-4031 and chromanol 293B; second dose 5 second concentration of each drug, respectively 1024, 1026, and 1025 M for d,l-sotalol, E-4031 and chromanol 293B.
*p , 0.05 versus control.
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could be an important arrhythmogenic factor. Indeed,
increased variability of QT interval duration was observed in
many human cardiac diseases and seems to be a good
marker of arrhythmogenicity (7,29). This faster adaptation
of QT interval to changes in HR, often called “repolariza-
tion lability” (30), agrees with an alteration of repolarization
dynamics and could facilitate arrhythmias in affected dogs.
Abnormal IKs? Previous patch-clamp studies have shown a
decreased Ito in epicardial myocytes of affected dogs. This
was proposed as the mechanism of AP prolongation (31).
However, a specific block of Ito in vitro leads to a decrease
in APD on canine Purkinje fibers (32), which is not in
agreement with our results. Moreover, in ex vivo experi-
ments on canine ventricular samples, blocking Ito decreased
endocardial APD and diminished the notch of the epicar-
dial AP and the J-wave on ECG, without occurrence of
arrhythmias (33). Consequently, a reduced Ito cannot ex-
plain all the abnormalities of cardiac repolarization observed
in this model.
We, therefore, decided to characterize more precisely the
late phase of repolarization of affected dogs. We studied the
effects of specific blockers of the two components of IK.
E-4031 is a class III antiarrhythmic compound that specif-
ically blocks the rapid component of the delayed rectifier
current IKr (16,34). In agreement with previous studies (35),
we observed a major increase in APD caused by E-4031 on
both endomyocardial biopsies and Purkinje fibers. This
increase was similar in both groups of dogs, suggesting that
IKr may not be implicated in the abnormal cardiac repolar-
ization displayed by affected dogs.
Chromanol 293B is a specific IKs-blocker (17). As pre-
viously shown (36), we observed that chromanol 293B
slightly but significantly increased APD in unaffected dogs,
suggesting that IKs normally participates to cardiac repolar-
ization (36,37). In contrast, chromanol 293B had no effect
Figure 4. Left panels. Increase in APD90 induced by d,l-sotalol 10
25 M
(open symbols) and 1024M (solid symbols) as a function of PCL in (A)
endomyocardial biopsies of unaffected (n 5 7; circle) and affected dogs
(n 5 8; triangle; #, n 5 7) and (B) Purkinje fibers of unaffected (n 5 6);
circle) and affected dogs (n 5 5; triangle). In the affected group, the
number of experimental data decreased to 3 at PCL 5 4,000 ms under
sotalol 1025 and 1024 M and to 4 at PCL 5 2,000 ms under sotalol 1024
M because of the occurrence of early afterdepolarizations or triggered
activity. Right panels. (C) Typical action potentials recorded in endomyo-
cardial biopsies of an unaffected dogs (bottom) and an affected dog (top)
under control conditions (C) and in presence of d,l-sotalol 1025 M (1025)
and 1024 M (1024) at PCL 5 1,000 ms. Vertical bar, 50 mV; horizontal
bar, 100 ms. (D) Typical action potentials recorded from Purkinje fibers of
an unaffected dog (bottom) and an affected dog (top) in the presence of
d,l-sotalol 1024 M at PCL 5 8,000 ms. Vertical bar, 50 mV; horizontal
bar, 2 s. APD 5 action potential duration; PCL 5 pacing cycle length.
Figure 5. Left panels. Increase in APD90 induced by E-4031 10
27 M
(open symbols) and 1026 M (solid symbols) as a function of PCL in (A)
endomyocardial biopsies of unaffected (n 5 6; circle) and affected dogs
(n 5 7; triangle) and (B) Purkinje fibers of unaffected (n 5 9; circle) and
affected dogs (n 5 5; triangle). At PCL 5 4,000 ms, the number of
experimental data decreased to 4 under E-4031 1027 and 1026 M in the
unaffected group and to 4 under E-4031 1027 M and 2 under 1026 M in
the affected group because of the occurrence of early afterdepolarizations or
triggered activity. Right panels. Typical action potentials recorded in (C)
endomyocardial biopsies and (D) Purkinje fibers of affected dogs (top) and
unaffected dogs (bottom) under control conditions (C) and in the presence
of E-4031 1027 M (1027 for Purkinje fibers only) and 1026 M (1026) at
PCL 5 1,000 ms. Vertical bar, 50 mV; horizontal bars, 100 ms in (C)
and 200 ms in (D). APD 5 action potential duration; PCL 5 pacing cycle
length.
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on affected dogs. This strongly suggests that IKs is absent in
affected dogs. Other arguments support the hypothesis of an
altered IKs. As discussed above in affected dogs, the APD is
5% to 10% longer than it is in unaffected dogs at a cycle
length of 1,000 ms. This corresponds roughly to the
percentage of 293B-induced prolongation of APD in unaf-
fected dogs (Table 4). Moreover, the slope of the APD-rate
relationship is steeper in affected dogs. Such a strong
bradycardia-induced APD prolongation is also observed in
M cells and has been imputed to a weak IKs (35). Finally, in
a previous study, we have shown that isoproterenol induces
a paradoxical increase in APD in affected dogs, while APD
is normally shortened in control dogs (12). This abnormal
effect of isoproterenol is expected when IKs is abnormal or
absent. Indeed, isoproterenol prolongs APD on myocar-
dium in the presence of chromanol 293B, whereas it
decreases APD when used alone (36,37). An alternative
explanation for the lack of 293B effects would be that a
mutation on the channel transporting IKs would disrupt the
binding site of this compound. However, this would not
explain the prolonged APD. We can, therefore, hypothesize
that the AP prolongation in affected dogs on both Purkinje
fibers and myocardium is due to a decreased IKs.
Mechanisms for an altered IKs. To explain an abnormal
IKs, we can either hypothesize a mutation on genes encoding
for the proteins supporting this ionic current or a dysfunc-
tion in its maturation process. The IKs current is formed by
the coassembly of two proteins, KvLQT1 (the channel) and
IsK (the regulator), encoded respectively by the KCNQ1
and KCNE1 genes (38). Mutations on these genes are
responsible for two different long QT syndromes in hu-
mans, respectively LQT1 (39) and LQT5 (40). The abnor-
mality observed in affected dogs of this genetic model could,
therefore, be due to a mutation on either KCNQ1 or
KCNE1. But it can also be linked to an abnormal expres-
sion of one of these two genes mediated by the autonomic
nervous system (ANS). Indeed, ANS stimulation and de-
velopment may play a role in the genesis of arrhythmias
(1,7,41). Neuromediators of ANS are suggested to play a
role in the maturation of cardiac cells and molecular
structures, especially ionic channels. In vitro experiments
using neuromediators or hormones can modify the expres-
sion of ionic channels (42,43). Abnormal development of
ANS may, therefore, lead to abnormal expression of ionic
channels (7).
Dae et al. (44) showed that affected dogs have a hetero-
geneous cardiac sympathetic innervation. This could lead to
an abnormal expression of genes encoding for ionic channels
in affected dogs, and it explains the decreased Ito observed
on epicardial myocytes (31) and the decreased IKs suggested
by our results on endomyocardium and Purkinje fibers. The
prolongation of PR interval may also be due to this
heterogeneous innervation and may implicate an abnormal
expression of genes encoding for sodium or calcium chan-
nels.
Conclusions. We conclude that abnormal repolarization
might be the cause of arrhythmias in this canine genetic
syndrome. This abnormality may be due to an abnormal
sympathetic innervation and may implicate dysfunctions of
the potassium channel responsible for IKs. This would lead
to electrogenic instability of cardiac tissue responsible for
the prolongation of repolarization on myocardium and
Purkinje fibers, the occurrence of EADs and TA on
Purkinje fibers and the faster kinetics of adaptation of
repolarization to changes in cardiac rate. Further investiga-
tions are expected to confirm a mutation or an abnormal
expression of genes encoding for ionic channels.
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Figure 6. Left panels. Increase in APD90 induced by 293B 10
26 M (open
symbols) and 1025 M (solid symbols) as a function of PCL in (A)
endomyocardial biopsies of unaffected (n 5 6; circle) and affected dogs
(n 5 5; triangle) and (B) Purkinje fibers of unaffected (n 5 9; circle) and
affected dogs (n 5 5; triangle). Right panels. Typical action potentials
recorded in (C) endomyocardial biopsies and (D) Purkinje fibers of affected
dogs (top) and unaffected dogs (bottom) under control conditions (C) and
in the presence of 293B 1025 M (1025) at PCL 5 1,000 ms. Vertical bar,
50 mV; horizontal bars, 100 ms in (C) and 200 ms in (D). APD 5 action
potential duration; PCL 5 pacing cycle length.
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